BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8135801)

  • 1. Point mutations of the thyrotropin receptor determining structural requirements for its ability to bind thyrotropin and to stimulate adenylate cyclase activity.
    Gustavsson B; Westermark B; Heldin NE
    Biochem Biophys Res Commun; 1994 Mar; 199(2):612-8. PubMed ID: 8135801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1754-62. PubMed ID: 1336379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.
    Duprez L; Parma J; Van Sande J; Allgeier A; Leclère J; Schvartz C; Delisle MJ; Decoulx M; Orgiazzi J; Dumont J
    Nat Genet; 1994 Jul; 7(3):396-401. PubMed ID: 7920658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G
    Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
    Kosugi S; Kohn LD; Akamizu T; Mori T
    Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
    Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
    Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
    Zhang ML; Sugawa H; Kosugi S; Mori T
    Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
    Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
    Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of TSH receptor mutations in three families with resistance to TSH.
    Tonacchera M; Di Cosmo C; De Marco G; Agretti P; Banco M; Perri A; Gianetti E; Montanelli L; Vitti P; Pinchera A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):712-8. PubMed ID: 17697008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine-699, a possible palmitoylation site of the thyrotropin receptor, is not crucial for cAMP or phosphoinositide signaling but is necessary for full surface expression.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1996 Apr; 221(3):636-40. PubMed ID: 8630013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure.
    Akamizu T; Inoue D; Kosugi S; Kohn LD; Mori T
    Thyroid; 1994; 4(1):43-8. PubMed ID: 8054860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino-terminal half of the cytoplasmic tail of the thyrotropin receptor is essential for full activities of receptor function.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1994 Apr; 200(1):401-7. PubMed ID: 8166712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
    Du K; Nicole P; Couvineau A; Laburthe M
    Biochem Biophys Res Commun; 1997 Jan; 230(2):289-92. PubMed ID: 9016768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the thyrotropin receptor by mutating CYS-636 in the sixth transmembrane segment.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1996 May; 222(3):713-7. PubMed ID: 8651910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of regions in the human angiotensin II receptor type 1 responsible for Gi and Gq coupling by mutagenesis study.
    Shibata T; Suzuki C; Ohnishi J; Murakami K; Miyazaki H
    Biochem Biophys Res Commun; 1996 Jan; 218(1):383-9. PubMed ID: 8573166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis.
    Ehrlich GK; Andria ML; Zheng X; Kieffer B; Gioannini TL; Hiller JM; Rosenkranz JE; Veksler BM; Zukin RS; Simon EJ
    Can J Physiol Pharmacol; 1998 Mar; 76(3):269-77. PubMed ID: 9673790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.
    Derwahl M; Kuemmel M; Goretzki P; Schatz H; Broecker M
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1131-8. PubMed ID: 8385451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.